COVID-19 updates: Classes in Chicago canceled for 4th day

Chicago Public Schools has been in talks with teachers over COVID-19 safety.

As the COVID-19 pandemic has swept the globe, more than 5.4 million people have died from the disease worldwide, including over 837,000 Americans, according to real-time data compiled by Johns Hopkins University's Center for Systems Science and Engineering.

About 62.5% of the population in the United States is fully vaccinated against COVID-19, according to data from the Centers for Disease Control and Prevention.


0

Mayo Clinic lays off 1% of staff for vaccine noncompliance

Mayo Clinic said it will lay off about 1% of its staff for failing to get at least one dose of the COVID-19 vaccine by a company deadline.

"While Mayo Clinic is saddened to lose valuable employees, we need to take all steps necessary to keep our patients, workforce, visitors and communities safe. If individuals released from employment choose to get vaccinated at a later date, the opportunity exists for them to apply and return to Mayo Clinic for future job openings," Mayo Clinic said in a statement to ABC.

Last October, Mayo Clinic had set a Jan. 3 deadline for all employees to get at least their first vaccine dose or face dismissal.

The health care organization said the number of staffers being let go was "comparable to what other health care organizations have experienced in implementing similar vaccine requirement programs."

Mayo Clinic employs about 73,000 people, according to its website.


FDA: Do not swab your throat with at-home COVID-19 tests

The FDA is warning people not to swab their throats as part of an at-home COVID-19 test.

In a statement obtained by ABC News, the FDA said that is not how the tests were designed and it could pose a safety concern.

"The FDA advises that COVID-19 tests should be used as authorized, including following their instructions for use regarding obtaining the sample for testing," the statement said.

Social media posts promoting at-home COVID-19 rapid test swabbing techniques claim that throat swabs collect a better sample. However, this hasn't been proven for currently authorized tests.

- ABC News' Sony Salzman


Biden doubles Pfizer antiviral pill purchase

President Joe Biden announced Tuesday afternoon that he was doubling the federal government's purchases of Pfizer's COVID-19 antiviral pill, from 10 million to 20 million treatment courses.

"They’re a gamechanger and have the potential to dramatically alter the impact of COVID-19, the impact it's had on this country and our people,” Biden said.

He also warned that those who remain unvaccinated "will die" during the ongoing omicron surge.

“So there's no excuse, no excuse, for anyone being unvaccinated,” Biden said.

-ABC News' Ben Gittleson


US now averaging nearly 500,000 daily cases, data shows

Data released by the Centers for Disease Control and Prevention from the weekend shows that the U.S. is now averaging nearly half a million new cases a day.

About a year ago, the U.S. was reporting an average of about 216,000 new cases a day. However, compared to last winter, hospital admissions and daily deaths are notably lower.

Over the last week, the U.S. reported more than 3.4 million new cases -- roughly averaging out to nearly six Americans testing positive every second.

-ABC News' Arielle Mitropoulos


White House confident it can deliver 500 million COVID tests this month

The White House said Wednesday it is confident it can deliver millions of rapid COVID-19 tests to Americans in January.

Last month, the administration announced it was planning to distribute 500 million free at-home rapid tests across the country to combat the surging omicron variant.

However, a website has yet to be launched where people can order the tests and the U.S. is currently producing less than half of the tests needed -- 200 million a month.

During a virtual briefing, Jeff Zients, the White House Coronavirus Response Coordinator, said the government not only has the capacity to deliver 500 million tests, but it also won't dip into the current supply on pharmacy shelves.

"With all the companies that now have been authorized, there’s the capacity for the U.S. government to purchase the 500 million now and not disrupt, or in any way cannibalize, the tests that are on pharmacy shelves and on websites and used and other settings," he said.

-ABC News' Cheyenne Haslett